The U.S. Food and Drug Administration provided the Star Tribune with a long-lost database of postsurgical complications following 1,039 surgeries using Medtronic's Infuse product. Most cases were in the lower back, where the product is approved for some uses, but more than 100 were in the upper spine, where use is "off label" and complications can be life-threatening. Some patients had multiple complications.
All 1,039 postsurgical complications after surgeries using Medtronic's Infuse product
The U.S. Food and Drug Administration provided the Star Tribune with a long-lost database of postsurgical complications following 1,039 surgeries using Medtronic's Infuse product.
December 16, 2018 at 3:05AM
about the writer
The holidays aren’t the time to question Minnesotans’ generosity. Neither is an election year.
